FDA finds deficiencies in Mylan's generic Advair

(Reuters) - U.S. drugmaker Mylan NV said on Wednesday that U.S. health regulators could not approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug, Advair, and cited "minor deficiencies" with the copycat version.

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Rescued Indian and Irish sailors head for remote island

An Indian and an Irish sailor rescued from damaged sailboats in the remote southern Indian Ocean will be delivered to land on Tuesday when they reach an island and undergo medical assessments, an official said.

0 0

LIVE UPDATES: New Brunswick Tories and Liberals in apparent dead heat

Voters in New Brunswick turned their backs on the province's entrenched two-party system for the first time on Monday, electing enough third party candidates to leave the Liberals and Progressive Conservatives in an apparent dead heat in what is sure to b...

0 0

Nicaragua issues arrest warrant for opposition leader

A Managua judge issued an arrest warrant on Monday for opposition leader Felix Maradiaga, accused by the Nicaraguan government of financing violent protests that have rocked the impoverished Central American nation.

0 0

Whoops, looks like something went wrong.